Skip to main content

35 publications

Name Date Type Actions

ANNUAL RESULTS 2023 (slideshow)

01.2023 Highlights
02.2023 Consolidated financial statements
03.Strategy and outlook

20/03/2024 Annual Report

[VIDEO] Présentation des résultats annuels 2022 -French

Présentation analystes & investisseurs - 23 Mars 2023

23/03/2023 Annual Report

ANNUAL RESULTS 2022 (slideshow)

01.2022 Highlights
02.2022 Consolidated financial statements
03.Strategy and outlook

23/03/2023 Annual Report

Annual results 2021 (slideshow)

This document was prepared by Vetoquinol for the sole purpose of presenting the annual results for the year 2021 on March 24, 2022.

24/03/2022 Annual Report

[AUDIO] Présentation des résultats 2021

Présentation analystes & investisseurs - 24 mars 2022

24/03/2022 Annual Report

[VIDEO ]Présentation des résultats 2020 - french

Présentation analystes & investisseurs - 1er avril 2021

01/04/2021 Annual Report

Vetoquinol acquires the rights for Profender® from Elanco Animal Health for Canada

February 8th, 2021 (Lure, France) - Vetoquinol announced today the acquisition of the Canadian rights to Profender® product family from Elanco Animal Health.

08/02/2021 press release excluding results

[AUDIO] Présentation des résultats 2019

Présentation analystes & investisseurs - 26 mars 2020

26/03/2020 Annual Report

2019 annual results

 
 

 

 

26/03/2020 Annual Report

2018 Annual results

21/03/2019 Annual Report

[AUDIO] Présentation des résultats 2017

Présentation analystes & investisseurs - 15 mars 2018

22/03/2018 Annual Report

2017 Results

Investors and Analysts - March 15, 2018

15/03/2018 Annual Report

Présentation des résultats 2016 - french

Vétoquinol - 23.03.2017 - 18h15 - Enregistrement Audio Conference

28/03/2017 Annual Report

2016 Annual Results

Présentation analystes & investisseurs - 23 mars 2017

23/03/2017 Annual Report

2015 Annual Results

2015 Annual Results

22/03/2016 Annual Report

2014 annual results

Sustained growth, Reference products drive growth in 2014.
<br />
2014 key figures.

24/03/2015 Annual Report

2013 annual results

SFAF meeting March 13, 2014

18/03/2014 Annual Report

Vétoquinol : 80 years striving for animal health worldwide

Founded in 1933, Vétoquinol is now a leading global animal health company.
The number 10 global animal health company and the third
largest in France, the Vétoquinol Group combines sustainability,
growth and independence in an increasingly competitive world
market.
Committed to the protection and well-being of both animals
and people, Vétoquinol creates, develops and sells veterinary
drugs and non-medical products all over the world.
The company is widely reputed for its expertise in the fields of infectious diseases, pain and inflammation in livestock (cattle and pigs) and pets (dogs and cats).
For over 80 years, Vétoquinol's pursuit of growth has been underpinned by strong values of team spirit, performance and the sharing of corporate culture and know-how with customers, vets, breeders, partners and employees alike.

17/05/2013 Annual Report

Financial statements 2012

1.1CONSOLIDATED FINANCIAL STATEMENTS p.4

30/04/2013 Annual Report

2012 ANNUAL RESULTS

SFAF Meeting March 27, 2013

28/03/2013 Annual Report

2011 ACTIVITY REPORT

Our business: animals. Our advantage: people.

12/04/2012 Annual Report

2011 ANNUAL RESULTS

SFAF meeting April 4, 2012

05/04/2012 Annual Report

2010 Activity Report

P_06 VÉTOQUINOL’S PROUD HISTORY
<br>
P_12 SPOTLIGHT ON INNOVATION
<br>
P_18 AN ONGOING DAILY COMMITMENT
TO VETERINARIANS
<br>
P_24 AN INTERNATIONAL COMPANY
MAINTAINING A LOCAL PRESENCE
IN GLOBAL MARKETS
<br>
P_28 GOVERNANCE AND KEY FIGURES

27/04/2011 Annual Report

2010 annual earnings Vétoquinol

Contents :
<br>> Highlights
<br>> 2010 Consolidated
Financial Statements
<br>> Strategy and Outlook
<br>> Questions and Answers

12/04/2011 Annual Report

2009 activity report

21/04/2010 Annual Report

2009 Annual earnings

2009 Annual earnings

01/04/2010 Annual Report

Rapport financier semestriel 2009 (french)

Le chiffre d’affaires de Vétoquinol pour le 1er semestre 2009 s’établit à 119,9 M€, en croissance de 2,7% par rapport au premier semestre de l’exercice précédent.

01/09/2009 Annual Report

Vétoquinol: H1 2009 interim earnings

01/09/2009 Annual Report

2008 activity report

25/05/2009 Annual Report

2008 Annual earnings

Operating highlights
- Key figures
- Revenues
- External growth
- A strategy of product innovation

01/04/2009 Annual Report

Rapport semestriel Vétoquinol 2008 (french)

Vétoquinol a réalisé de bons résultats au premier semestre 2008 : le chiffre d’affaires
progresse de 5,0% et le résultat net après impôts de 15,3%.

07/10/2008 Annual Report

Vétoquinol: H1 2008 interim earnings

27/08/2008 Annual Report

Activity Report 2007

19/05/2008 Annual Report

2007 annual earnings Vétoquinol

19/03/2008 Annual Report

Etats financiers consolidés au 31 décembre 2006 (french)

10/05/2007 Annual Report